Pay in 4 interest-free payments of $26.25 Learn more
Ships within 48 hours · Estimated delivery Oct 20 - Oct 25
The highly polar carboxylate group of GSK-J1 restricts its cellular permeability
Solubility: DMSO: 76 mg/mL(200
CAS Number: 929016-96-6
several Saccharomyces cerevisiae mutants were screened and tested
Kurumaji A
Tipranavir Catalog No.:M10307-2 The highly polar carboxylate groupTipranavir is a nonpeptidic protease inhibitor. Tipranavir has the ability to inhibit the replication of viruses that are resistant to other protease inhibitors and it recommended for patients who are resistant to other treatments. Resistance to tipranavir itself seems to require multiple mutations. Tipranavir was approved by the Food and Drug Administration (FDA) on June 22, 2005, and was approved for pediatric use on June 24, 2008. Like lopinavir
US$ 81.00
US$ 46.80
US$ 28.80
US$ 11.00
US$ 149.00
US$ 11.00
US$ 12.00
US$ 59.00
US$ 22.00
US$ 125.00